Skip to main content
Cardiosense Recieves FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure Read the press release

Media Coverage

FDA clears catheter-free heart failure monitor

Downtown high-rise office towers

Keep reading